Baxter International Inc. (BAX) Q1 2026 Earnings Call Transcript
Baxter International Inc. reported its first-quarter 2026 earnings on April 30, 2026, surpassing expectations with adjusted earnings per share of $0.36 and revenue of $2.70 billion, which represented a 2.9% year-over-year increase. The company highlighted performance across its medical products and therapies segments amid ongoing leadership transitions. Executives discussed financial results and strategic priorities during the earnings call, which included participation from members of the investor relations and executive teams.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4896689-baxter-international-inc-bax-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
